Patents by Inventor Mark D. Kollar

Mark D. Kollar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200268715
    Abstract: The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
    Type: Application
    Filed: May 12, 2020
    Publication date: August 27, 2020
    Inventor: Mark D. Kollar
  • Patent number: 10456377
    Abstract: The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: October 29, 2019
    Assignee: St. Renatus, LLC
    Inventor: Mark D. Kollar
  • Patent number: 10420750
    Abstract: The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: September 24, 2019
    Assignee: ST. RENATUS, LLC
    Inventor: Mark D. Kollar
  • Patent number: 9889109
    Abstract: The present invention relates to intranasally administered pharmaceutical compositions for the treatment of headaches, such as migraines. Such pharmaceutical compositions comprise benzyl alcohol or a combination of benzyl alcohol and tetracaine. The invention also relates to methods for treating headaches, such as migraines, using these pharmaceutical compositions.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: February 13, 2018
    Assignee: ST. RENATUS, LLC
    Inventor: Mark D. Kollar
  • Patent number: 9855247
    Abstract: The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: January 2, 2018
    Assignee: St. Renatus, LLC
    Inventor: Mark D. Kollar
  • Publication number: 20170360718
    Abstract: The present invention relates to intranasally administered pharmaceutical compositions administered for use in anesthesia. Such pharmaceutical compositions comprise benzyl alcohol. The invention also relates to methods for anesthetizing the maxillary dental arch using these pharmaceutical compositions.
    Type: Application
    Filed: June 1, 2017
    Publication date: December 21, 2017
    Inventor: Mark D. Kollar
  • Publication number: 20170326112
    Abstract: The present invention relates to tetracaine based anesthetic formulations and methods of use thereof The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
    Type: Application
    Filed: April 27, 2017
    Publication date: November 16, 2017
    Inventor: Mark D. Kollar
  • Publication number: 20170326111
    Abstract: The present invention relates to tetracaine based anesthetic formulations and methods of use thereof The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
    Type: Application
    Filed: April 27, 2017
    Publication date: November 16, 2017
    Inventor: Mark D. Kollar
  • Publication number: 20170319547
    Abstract: The present invention relates to tetracaine based anesthetic formulations and methods of use thereof The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
    Type: Application
    Filed: April 18, 2017
    Publication date: November 9, 2017
    Inventor: Mark D. Kollar
  • Publication number: 20160184269
    Abstract: The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
    Type: Application
    Filed: March 2, 2016
    Publication date: June 30, 2016
    Inventor: Mark D. Kollar
  • Publication number: 20150246017
    Abstract: The present invention relates to intranasally administered pharmaceutical compositions for the treatment of headaches, such as migraines. Such pharmaceutical compositions comprise benzyl alcohol or a combination of benzyl alcohol and tetracaine. The invention also relates to methods for treating headaches, such as migraines, using these pharmaceutical compositions.
    Type: Application
    Filed: September 27, 2013
    Publication date: September 3, 2015
    Applicant: ST. RENATUS, LLC
    Inventor: Mark D. Kollar